Lorenz H - Search Results

1

Determination of thromboxane formation, soluble CD40L release and thrombopoietin clearance in apheresis platelet concentrates.

Wenzel F, Baertl A, Hohlfeld T, Zimmermann N, Weber AA, Lorenz H, Giers G. Wenzel F, et al. Among authors: lorenz h. Platelets. 2012;23(2):150-6. doi: 10.3109/09537104.2011.599897. Epub 2011 Aug 2. Platelets. 2012. PMID: 21806498

2

Fetal alloimmune thrombocytopenia and maternal intravenous immunoglobulin infusion.

Giers G, Wenzel F, Stockschläder M, Riethmacher R, Lorenz H, Tutschek B. Giers G, et al. Among authors: lorenz h. Haematologica. 2010 Nov;95(11):1921-6. doi: 10.3324/haematol.2010.025106. Epub 2010 Jun 9. Haematologica. 2010. PMID: 20534698 Free PMC article.

3

Retrospective comparison of maternal vs. HPA-matched donor platelets for treatment of fetal alloimmune thrombocytopenia.

Giers G, Wenzel F, Fischer J, Stockschläder M, Riethmacher R, Lorenz H, Tutschek B. Giers G, et al. Among authors: lorenz h. Vox Sang. 2010 Apr;98(3 Pt 2):423-30. doi: 10.1111/j.1423-0410.2009.01268.x. Epub 2009 Oct 27. Vox Sang. 2010. PMID: 19874573

4

Repeated intrauterine IgG infusions in foetal alloimmune thrombocytopenia do not increase foetal platelet counts.

Giers G, Wenzel F, Riethmacher R, Lorenz H, Tutschek B. Giers G, et al. Among authors: lorenz h. Vox Sang. 2010 Nov;99(4):348-53. doi: 10.1111/j.1423-0410.2010.01367.x. Vox Sang. 2010. PMID: 20624268

5

Influence of argatroban on coagulation parameters in heparin-induced thrombocytopenia patients after cardiothoracic surgery.

Harder S, Merz M, Klinkhardt U, Lorenz H, Koster A. Harder S, et al. Among authors: lorenz h. J Thromb Haemost. 2007 Sep;5(9):1982-4. doi: 10.1111/j.1538-7836.2007.02662.x. J Thromb Haemost. 2007. PMID: 17723141 Free article. No abstract available.

6

CAR T-Cell Therapy in Autoimmune Disease.

Merkt W, Lorenz HM, Schmitt M. Merkt W, et al. Among authors: lorenz hm. N Engl J Med. 2024 May 2;390(17):1628-1629. doi: 10.1056/NEJMc2403705. N Engl J Med. 2024. PMID: 38692297 No abstract available.

7

bDMARD can prevent the progression of AA amyloidosis to end-stage renal disease.

Kvacskay P, Hegenbart U, Lorenz HM, Schönland SO, Blank N. Kvacskay P, et al. Among authors: lorenz hm. Ann Rheum Dis. 2024 Apr 23:ard-2023-225114. doi: 10.1136/ard-2023-225114. Online ahead of print. Ann Rheum Dis. 2024. PMID: 38653531

8

Fibroblast Activation Protein Inhibitor-Positron Emission Tomography in Aortitis: Fibroblast pathology in active inflammation and remission.

Röhrich M, Rosales JJ, Hoppner J, Kvacskay P, Blank N, Loi L, Paech D, Schreckenberger M, Giesel F, Kauczor HU, Lorenz HM, Haberkorn U, Merkt W. Röhrich M, et al. Among authors: lorenz hm. Rheumatology (Oxford). 2024 Apr 22:keae225. doi: 10.1093/rheumatology/keae225. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38648749

9

Impact of DMARD treatment and systemic inflammation on all-cause mortality in patients with rheumatoid arthritis and interstitial lung disease: a cohort study from the German RABBIT register.

Rudi T, Zietemann V, Meissner Y, Zink A, Krause A, Lorenz HM, Kneitz C, Schaefer M, Strangfeld A. Rudi T, et al. Among authors: lorenz hm. RMD Open. 2024 Apr 4;10(2):e003789. doi: 10.1136/rmdopen-2023-003789. RMD Open. 2024. PMID: 38580343 Free PMC article.

10

Aqueous solution and solid-state behaviour of l-homophenylalanine: experiment, modelling, and DFT calculations.

Tenberg V, Sadeghi M, Schultheis A, Joshi M, Stein M, Lorenz H. Tenberg V, et al. Among authors: lorenz h. RSC Adv. 2024 Apr 2;14(15):10580-10589. doi: 10.1039/d4ra01897d. eCollection 2024 Mar 26. RSC Adv. 2024. PMID: 38567323 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

726 results

Search Page